Symposium: What does the microbiome tell us about prevention and treatment of AD/ADRD?

Authors

Joia K Capocchi, University of California, Irvine
Claudia Figueroa-Romero, National Institute of Neurological Disorders and Stroke
Sage J B Dunham, University of California, Irvine
Gina Faraci, University of California, Irvine
Jason A Rothman, University of California, Irvine
Katrine L Whiteson, University of California, Irvine
Dong-Oh Seo, Washington University School of Medicine in St. Louis
David M Holtzman, Washington University School of Medicine in St. Louis
Stefanie Grabrucker, University College Cork, Ireland
Yvonne M Nolan, University College Cork, Ireland
Rima Kaddurah-Daouk, Duke University
David A Jett, National Institute of Neurological Disorders and Stroke

Journal

The Journal of neuroscience

Publication Date

10-9-2024

Volume

44

Issue

41

First Page

e1295242024

Document Type

Open Access Publication

DOI

10.1523/JNEUROSCI.1295-24.2024

Rights and Permissions

Capocchi JK, Figueroa-Romero C, Dunham SJB, Faraci G, Rothman JA, Whiteson KL, Seo DO, Holtzman DM, Grabrucker S, Nolan YM, Kaddurah-Daouk R, Jett DA. Symposium: What Does the Microbiome Tell Us about Prevention and Treatment of AD/ADRD? J Neurosci. 2024 Oct 9;44(41):e1295242024. doi: 10.1523/JNEUROSCI.1295-24.2024. Copyright © 2024 the authors.

Recommended Citation

Capocchi, Joia K; Figueroa-Romero, Claudia; Dunham, Sage J B; Faraci, Gina; Rothman, Jason A; Whiteson, Katrine L; Seo, Dong-Oh; Holtzman, David M; Grabrucker, Stefanie; Nolan, Yvonne M; Kaddurah-Daouk, Rima; and Jett, David A, "Symposium: What does the microbiome tell us about prevention and treatment of AD/ADRD?." The Journal of neuroscience. 44, 41. e1295242024 (2024).
https://digitalcommons.wustl.edu/oa_4/4526

Department

ICTS (Institute of Clinical and Translational Sciences)